Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with G-CSF may make tumor cells more sensitive to the chemotherapy drug and may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of mitoxantrone plus G-CSF in treating patients with metastatic prostate cancer that has not responded to hormone therapy.

Key facts

Study ID

NCT00003183

Run by

Hope Cancer Institute, Inc.

People needed

64

Starts

1997-03-01

Last updated by the study team

2013-12-04

Who can join

Age: any. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Bethany Medical Center — Kansas City, Kansas, United States
• Heartland Cancer Research and Treatment Center — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.